Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000046

Chief Scientific Officer sold 17,878 shares at an average $18.03 ($322,389)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sethuraman Natarajan Chief Scientific Officer 2023-07-10 Sale 10b5-1 −3,026 $18.00 $54,474 168,299 D
Sethuraman Natarajan Chief Scientific Officer 2023-07-11 Sale 10b5-1 −14,852 $18.04 $267,915 153,447 D
Open-market sales · 17,878 sh · avg $18.03 · $322,389
Loading xslF345X04/wf-form4_168919391527267.xml…